Kartos Therapeutics

1 trends tracked about this subject — the full history, oldest to newest below.

▲ Peaking Business

Ipsen’s $1.75B Kartos deal reshapes blood cancer drug development—here’s what’s driving the bid

6 sources 6 articles v 4 39m ago